Ari Bousbib, Chairman, Chief Executive Officer and President of Quintiles IMS Holdings, Inc. (NYSE:Q) said, ". In the quarter, I think we spent $180 million in acquisitions. We continuously look for and have a rich pipeline of small tuck-in capability acquisitions. These are, for the most part, and I want to say exclusively this year, technology acquisitions, both in the commercial space and the clinical space. This quarter, there were a few handful of small acquisitions, all of which closed at the end of the quarter and had 0 impact in the quarter. As we've told you before, we may pay a healthy premium because again, we're buying technology capabilities. It's a decision to continue to develop our assets through acquisitions instead of internal product development spend. Initially, this acquisitions have very little revenue contribution and the acquisition spend can be lumpy quarter-to-quarter. But that's what we signaled before. It's not rich. And we expect, to answer your question in terms of contribution to revenue, that acquisitions will contribute year in, year out, 1 point, 1.5 points to our growth, and this year won't be different."